Patents by Inventor Andrew W. Boyd

Andrew W. Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment
    Patent number: 7897570
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Grant
    Filed: January 14, 2008
    Date of Patent: March 1, 2011
    Assignees: The Walter and Eliza Hall Institute of Medical Research, The Council of the Queensland Institute of Medical Research, The University of Melbourne
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Treating Gliosis, Glial Scarring, Inflammation or Inhibition of Axonal Growth in the Nervous System by Modulating Eph Receptor
    Publication number: 20080254023
    Abstract: The present invention relates to a method of treating disorders of the nervous system and more particularly disorders associated with a gliotic response and/or an inflammatory response within the central nervous system and to therapeutic agents useful for same. More particularly, the present invention involves a method of preventing or reducing the amount of Eph receptor-mediated gliosis and/or glial scarring and/or inflammation and/or Eph receptor-mediated inhibition of axonal growth which occurs during and/or after disease or injury to the nervous system. The present invention also facilitates the identification of therapeutic agents which modulate Eph receptor-mediated signaling. The method and therapeutic agents of the present invention are useful for treating a range of nervous system diseases, conditions and injuries including, inter alia, paralysis induced by physiological-, pathological- or trauma-induced injury to the brain or spinal cord.
    Type: Application
    Filed: September 8, 2005
    Publication date: October 16, 2008
    Applicants: THE UNIVERSITY OF QUEENSLAND, THE UNIVERSITY OF MELBOURNE
    Inventors: Perry F. Bartlett, Mary P. Galea, Yona Goldsmith, Ann M. Turnley, Andrew W. Boyd
  • Method of treatment
    Publication number: 20080255044
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Application
    Filed: January 14, 2008
    Publication date: October 16, 2008
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Method of treatment
    Patent number: 7341997
    Abstract: The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated.
    Type: Grant
    Filed: April 7, 2005
    Date of Patent: March 11, 2008
    Assignees: The Walter and Eliza Hall Institute of Medical Research, The Council of the Queensland Institute of Medical Research, The University of Melbourne
    Inventors: Perry F. Bartlett, Lynne Hartley, Mark Pouzzotto, Trevor Kilpatrick, Frank Kontgen, Jason Coonan, Ursula Greferath, Andrew W. Boyd, Mirella Dottori, Mary P. Galea, George Paxinos, Mark Murphy
  • Method for screening for soluble ligands to a receptor-type tyrosine kinase
    Patent number: 6599709
    Abstract: The present invention relates to a method of screening for ligands to a receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: July 29, 2003
    Assignee: The Walter and Eliza Hall Institute of Medical Research
    Inventors: Andrew W. Boyd, Richard Simpson, Ian Wicks, Larry David Ward, David Wilkinson
  • Receptor-type tyrosine kinase and use thereof
    Patent number: 6020306
    Abstract: The present invention relates to an isolated receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: September 18, 1996
    Date of Patent: February 1, 2000
    Assignee: Amrad Corporation Limited
    Inventors: Andrew W. Boyd, Richard Simpson, Ian Wicks, Larry David Ward, David Wilkinson
  • Method of screening for ligands to a receptor-type tyrosine kinase
    Patent number: 5674691
    Abstract: The present invention relates to a method of screening for ligands to a receptor-type tyrosine kinase. The receptor-type tyrosine, in its naturally occurring form, is characterized by being reactive to monoclonal antibody III.A4, having an apparent molecular weight of approximately 120-150 kD in its glycosylated form, and having the N-terminal amino acid sequence E L I P Q P.
    Type: Grant
    Filed: April 18, 1994
    Date of Patent: October 7, 1997
    Assignee: Amrad Corporation Limited
    Inventors: Andrew W. Boyd, Richard John Simpson, Ian Wicks, Larry David Ward, David Wilkinson